Amycretin, a single molecule that combines GLP-1 and amylin activity in both oral and injectable forms, and survodutide, a GLP-1 and glucagon agonist aimed heavily at liver disease, have both advanced into Phase 3
It is crucial to distinguish between medically indicated B12 replacement therapy and commercially marketed wellness injections, as they serve fundamentally different purposes and are subject to different regulatory oversight
The honest limitation: a narrower peptide and longevity menu than the peptide-first platforms, and a lighter clinical layer than the top pick, so complex multi-compound protocols belong elsewhere
If you do not eat very healthy and you eat packed, very sweet or salty foods and alcohol, your body needs serious detoxification
Aminochrome induces irreversible mitochondrial dysfunction by inducing autophagy dysfunction in Parkinson's Disease